Equities Research Analysts’ upgrades for Tuesday, October 24th:

Bloomsbury Publishing Plc (LON:BMY) was upgraded by analysts at Numis Securities Ltd to a buy rating. Numis Securities Ltd currently has GBX 210 ($2.77) target price on the stock, up from their previous target price of GBX 205 ($2.71).

Brooks Macdonald Group plc (LON:BRK) was upgraded by analysts at Numis Securities Ltd to an add rating. Numis Securities Ltd currently has GBX 2,300 ($30.35) target price on the stock, up from their previous target price of GBX 2,250 ($29.69).

Open Text Corporation (NASDAQ:OTEX) (TSE:OTC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $38.00 price target on the stock. According to Zacks, “Open Text Corporation is engaged in development of innovative intranet, extranet and e-Business applications. Since creating one of the first search engines to index the World Wide Web, the company has remained at the forefront of Internet-based technologies. Open Text solutions allow individuals, teams, organizations, and global trading communities to collaborate on projects, share ideas and accelerate innovation to the fastest possible speed. Open Text Corporation is headquartered in Waterloo, Canada. “

Plains Group Holdings, L.P. (NYSE:PAGP) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $23.00 price target on the stock. According to Zacks, “Plains GP Holdings, L.P. operates as a holding company. The Company, through its subsidiaries, is involved in the transportation, storage, terminalling, and marketing of crude oil and refined products. It also focuses on the processing, transportation, fractionation, storage, and marketing of natural gas liquids, including ethane and natural gasoline products, as well as propane and butane products. Plains GP Holdings, L.P. is based in Houston, Texas. “

Pfenex (NYSEMKT:PFNX) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $3.00 price target on the stock. According to Zacks, “Pfenex Inc. is a clinical-stage biotechnology company developing and commercializing proteins. The company’s lead product candidate is PF582, a biosimilar candidate to Lucentis, for the potential treatment of patients with retinal diseases. It leverages its Pf?nex Expression Technology (TM) platform to build a pipeline of product candidates and preclinical products under development including other biosimilars, as well as vaccines, generics and next generation biologics. Pfenex Inc. is headquartered in San Diego, California. “

Pershing Gold Corporation (NASDAQ:PGLC) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Pershing Gold Corporation is engaged in the exploration and development of gold and precious metal properties primarily in Nevada. The Company focuses on the exploration of Relief Canyon properties located in Pershing County in northwestern Nevada. Pershing Gold Corporation is based in Lakewood, Colorado. “

Protalix Biotherapeutics (NYSEMKT:PLX) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $1.00 target price on the stock. According to Zacks, “Protalix is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx(R). Protalix’s unique expression system presents a proprietary method for developing recombinant proteins in a cost-effective, industrial-scale manner. Protalix’s first product manufactured by ProCellEx, taliglucerase alfa, was approved for marketing by the U.S. Food and Drug Administration (FDA) in May 2012 and, subsequently, by the regulatory authorities of other countries. Protalix has licensed to Pfizer Inc. the worldwide development and commercialization rights for taliglucerase alfa, excluding Brazil, where Protalix retains full rights. “

Asante Solutions (NASDAQ:PUMP) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “ProPetro Holding Corp. provides oilfield services. It offers hydraulic fracturing and other complementary services to leading upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. ProPetro Holding Corp. is headquartered in Midland, Texas. “

uniQure N.V. (NASDAQ:QURE) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “UNIQURE B.V. is involved in developing gene therapy for patients of genetic or acquired diseases. It offers Glybera for the treatment of lipoprotein lipase deficiency, an orphan metabolic disease. The company’s product pipeline includes which are in clinical trials are additional adeno-associated virus consist of AMT-060, AMT-021, AMT-110 and AAV2/glial. UNIQURE B.V. is headquartered in Amsterdam, the Netherlands. “

Reata Pharmaceuticals (NASDAQ:RETA) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is engaged in identifying, developing and commercializing product candidates which modulate the activity of regulatory proteins involved in the biology of mitochondrial function, oxidative stress and inflammation to address the unmet medical needs of serious or life-threatening diseases. Reata Pharmaceuticals, Inc. is based in Irving, United States. “

Shell Midstream Partners, L.P. (NYSE:SHLX) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Shell Midstream Partners, L.P. engages in owning, operating, developing and acquiring pipelines and other midstream assets. Its initial assets consist of interests in entities that own crude oil and refined products pipelines serving as key infrastructure to transport growing onshore and offshore crude oil production to Gulf Coast refining markets and to deliver refined products from those markets to major demand centers. Shell Midstream Partners, L.P. is based in Houston, Texas. “

Select Income REIT (NASDAQ:SIR) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Select Income REIT is a real estate company formed to primarily own and invest in net leased, single tenant properties. It has properties in Oahu, Hawaii and the mainland United States. Select Income REIT is headquartered in Newton, MA. “

SITO Mobile (NASDAQ:SITO) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “SITO Mobile Limited is a technology based mobile solutions provider. The Company provides wireless application development, publishing and distribution. It offers mobile location-based advertising and mobile messaging platforms that enable brands, agencies, and retailers to transform digital marketing by delivering targeted mobile advertising campaigns based on geo-location, in-store traffic, and customer response. SITO Mobile Limited, formerly known as Single Touch Systems, Inc., is based in Jersey City, New Jersey. “

Peak Resorts (NASDAQ:SKIS) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Peak Resorts, Inc. is an owner and operator of ski resorts in the U.S. The resorts under the company’s umbrella offer a breadth of activities, services and amenities, including skiing, snowboarding, terrain parks, tubing, dining, lodging, equipment rentals and sales, ski and snowboard instruction and mountain biking and other summer activities. Its ski properties are located throughout the Midwest, Northeast and Southeast United States. Peak Resorts, Inc. is headquartered in Wildwood, Missouri. “

Receive News & Ratings for Bloomsbury Publishing Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bloomsbury Publishing Plc and related companies with MarketBeat.com's FREE daily email newsletter.